EUR 22.9
(0.44%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 62.98 Million EUR | 1.86% |
2022 | 63.77 Million EUR | 14.27% |
2021 | 55.81 Million EUR | 50.52% |
2020 | 37.08 Million EUR | -31.97% |
2019 | 54.5 Million EUR | 29.48% |
2018 | 42.09 Million EUR | 8.01% |
2017 | 38.97 Million EUR | 11.8% |
2016 | 34.86 Million EUR | 9.72% |
2015 | 31.77 Million EUR | 37.51% |
2014 | 23.1 Million EUR | 14.86% |
2013 | 20.11 Million EUR | 11.59% |
2012 | 18.02 Million EUR | 7.39% |
2011 | 16.78 Million EUR | -2.5% |
2010 | 17.21 Million EUR | 30.33% |
2009 | 13.21 Million EUR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 33.09 Million EUR | 0.0% |
2023 Q4 | 31.45 Million EUR | 0.0% |
2023 FY | 64.96 Million EUR | 1.86% |
2023 Q2 | 23.5 Million EUR | 0.0% |
2022 Q2 | 20.2 Million EUR | 0.0% |
2022 Q4 | 19.56 Million EUR | 0.0% |
2022 FY | 63.77 Million EUR | 14.27% |
2021 Q2 | 13.9 Million EUR | 0.0% |
2021 Q4 | 31.64 Million EUR | 0.0% |
2021 FY | 55.81 Million EUR | 50.52% |
2020 FY | 37.08 Million EUR | -31.97% |
2020 Q2 | 23.84 Million EUR | 0.0% |
2020 Q4 | 18.51 Million EUR | 0.0% |
2019 Q2 | 26.28 Million EUR | 0.0% |
2019 FY | 54.5 Million EUR | 29.48% |
2019 Q4 | 26.71 Million EUR | 0.0% |
2018 Q2 | 21.18 Million EUR | 0.0% |
2018 Q4 | 23.18 Million EUR | 0.0% |
2018 FY | 42.09 Million EUR | 8.01% |
2017 Q2 | 20.2 Million EUR | 0.0% |
2017 FY | 38.97 Million EUR | 11.8% |
2017 Q4 | 23.32 Million EUR | 0.0% |
2016 Q2 | 18.01 Million EUR | 0.0% |
2016 Q4 | 22.13 Million EUR | 0.0% |
2016 FY | 34.86 Million EUR | 9.72% |
2015 Q4 | 17.84 Million EUR | 0.0% |
2015 Q2 | 17.12 Million EUR | 0.0% |
2015 FY | 31.77 Million EUR | 37.51% |
2014 Q2 | 11.57 Million EUR | 0.0% |
2014 Q4 | 15.45 Million EUR | 0.0% |
2014 FY | 23.1 Million EUR | 14.86% |
2013 Q4 | 14.52 Million EUR | 0.0% |
2013 FY | 20.11 Million EUR | 11.59% |
2013 Q2 | 10.35 Million EUR | 0.0% |
2012 Q2 | - EUR | 0.0% |
2012 Q4 | - EUR | 0.0% |
2012 FY | 18.02 Million EUR | 7.39% |
2011 FY | 16.78 Million EUR | -2.5% |
2011 Q4 | - EUR | 0.0% |
2011 Q2 | - EUR | 0.0% |
2010 FY | 17.21 Million EUR | 30.33% |
2010 Q4 | - EUR | 0.0% |
2009 FY | 13.21 Million EUR | 0.0% |
2009 Q4 | - EUR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Cegedim SA | 19.98 Million EUR | -215.173% |
Guerbet SA | 38.67 Million EUR | -62.864% |
Nexus AG | 24.76 Million EUR | -154.304% |
Bastide Le Confort Médical SA | 44.22 Million EUR | -42.42% |
Revenio Group Oyj | 26.34 Million EUR | -139.081% |
Drägerwerk AG & Co. KGaA | 171.18 Million EUR | 63.208% |
Sartorius Aktiengesellschaft | 541 Million EUR | 88.358% |
Siemens Healthineers AG | 2.86 Billion EUR | 97.805% |
Medios AG | 31.37 Million EUR | -100.762% |
Equasens Société anonyme | 55.2 Million EUR | -14.079% |
Stratec SE | 22.88 Million EUR | -175.17% |